Cholecalciferol versus ergocalciferol

Pro Research Analysisby

Searched over 200M research papers

Analyzed relevant papers

Cholecalciferol Versus Ergocalciferol: A Comparative Analysis

Introduction to Vitamin D Forms: Cholecalciferol and Ergocalciferol

Vitamin D is essential for maintaining bone health and calcium homeostasis. The two primary forms of vitamin D used in supplementation are cholecalciferol (D3) and ergocalciferol (D2). While both forms are used to treat vitamin D deficiency, their efficacy and potency have been subjects of ongoing research.

Efficacy in Increasing Serum 25-Hydroxyvitamin D Levels

Cholecalciferol's Superior Potency

Multiple studies have demonstrated that cholecalciferol is more effective than ergocalciferol in raising serum 25-hydroxyvitamin D [25(OH)D] levels. For instance, a study involving older adults found that cholecalciferol was slightly but significantly more effective than ergocalciferol in increasing serum 25(OH)D levels over a year of supplementation . Another study in hip fracture patients showed that cholecalciferol supplementation resulted in a 31% greater increase in total 25(OH)D compared to ergocalciferol .

Long-Term Efficacy

In chronic kidney disease (CKD) patients, cholecalciferol was found to be more effective at raising serum 25(OH)D levels during active therapy. However, both forms showed a significant decline in 25(OH)D levels after cessation of therapy, indicating the need for maintenance dosing . Additionally, a retrospective analysis in CKD patients revealed that cholecalciferol increased 25(OH)D levels more than twice as much as ergocalciferol .

Impact on Parathyroid Hormone and Calcium Levels

Comparable Effects on Parathyroid Hormone

Despite cholecalciferol's superior efficacy in raising 25(OH)D levels, both forms of vitamin D have shown comparable effects in reducing parathyroid hormone (PTH) levels. Studies in hip fracture patients and CKD patients found no significant differences between cholecalciferol and ergocalciferol in their effects on PTH levels 25.

Calcium Homeostasis

Cholecalciferol has been associated with a marginally greater increase in ionized calcium levels compared to ergocalciferol in treatment-adherent subjects . However, a small pilot study indicated that cholecalciferol might increase serum phosphorus concentrations more than ergocalciferol, suggesting potential differences in their impact on mineral metabolism .

Stability and Bioavailability

Stability Concerns

Ergocalciferol is less stable than cholecalciferol, being more susceptible to breakdown during storage and cooking. This instability may affect its efficacy as a dietary supplement .

Bioavailability

Both forms of vitamin D have shown comparable increases in their respective 25(OH)D metabolites when provided in low doses through fortified foods, indicating similar bioavailability in such contexts .

Conclusion

Overall, cholecalciferol (D3) appears to be more effective than ergocalciferol (D2) in increasing serum 25(OH)D levels, particularly in long-term supplementation. While both forms similarly reduce PTH levels, cholecalciferol may have a slight edge in improving calcium homeostasis. Given its greater stability and potency, cholecalciferol is generally preferred for vitamin D supplementation. However, individual responses can vary, and both forms remain viable options depending on specific patient needs and contexts.

Sources and full results

Most relevant research papers on this topic

Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults.

Cholecalciferol is slightly more effective than ergocalciferol in increasing serum 25(OH)D levels in older adults, with both showing significant between-individual response.

RCTVery Rigorous JournalHighly Cited

2011·

170citations

·N. Binkley et al.

Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol.

Both cholecalciferol and ergocalciferol effectively increase vitamin D levels in vitamin D-deficient hip fracture patients, with cholecalciferol showing slightly greater ionized calcium increase.

RCTRigorous Journal

2013·

45citations

·P. Glendenning et al.

Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly.

Cholecalciferol is nearly twice as potent as ergocalciferol in increasing serum 25(OH)D levels and modulating serum PTH in elderly female patients with vitamin D deficiency.

RCTRigorous JournalHighly Cited

2008·

325citations

·E. Romagnoli et al.

Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial

Cholecalciferol therapy is more effective than ergocalciferol for raising serum 25(OH)D in non-dialysis-dependent chronic kidney disease patients, but both require maintenance therapy to maintain levels.

RCTVery Rigorous Journal

2016·

23citations

·J. Wetmore et al.

Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol.

Cholecalciferol supplementation is more effective in increasing serum 25-hydroxyvitamin D levels than ergocalciferol in vitamin D-insufficient hip fracture patients, but their impact on PTH levels remains unclear.

RCTHighly Cited

2009·

101citations

·P. Glendenning et al.

Ergocalciferol versus Cholecalciferol for Nutritional Vitamin D Replacement in CKD

Cholecalciferol may be superior to ergocalciferol in treating nutritional vitamin D deficiency in non-dialysis chronic kidney disease, with younger females benefiting more.

Observational Study

2015·

14citations

·R. Mangoo‐Karim et al.

Ergocalciferol Versus Cholecalciferol in Non-Dialysis Dependent Chronic Kidney Disease Patients: A Small Retrospective Cohort Study.

Cholecalciferol treatment appears to increase serum phosphorous concentrations compared to ergocalciferol in non-dialysis chronic kidney disease patients.

Observational Study

2019·

1citation

·A. Al-Makki et al.

A comparison of the toxicity of ergocalciferol and cholecalciferol in rhesus monkeys (Macaca mulatta).

Cholecalciferol is significantly more toxic than ergocalciferol in rhesus monkeys, leading to hypercalcemia, death, and extensive soft tissue mineralization.

Non-RCTAnimal Study

1972·

58citations

·R. Hunt et al.

Fortified malted milk drinks containing low-dose ergocalciferol and cholecalciferol do not differ in their capacity to raise serum 25-hydroxyvitamin D concentrations in healthy men and women not exposed to UV-B.

Both low-dose ergocalciferol and cholecalciferol in fortified malted milk drinks effectively raise serum 25-hydroxyvitamin D concentrations in healthy men and women with negligible UV-B exposure.

RCTVery Rigorous Journal

2012·

39citations

·C. M. Fisk et al.

Vitamin D supplementation: cholecalciferol, calcifediol, and calcitriol

Cholecalciferol is the only form of vitamin D that should be considered for fortification and supplementation, as it is more stable, potent, and resistant to breakdown in cooking and baking compared to ergocalciferol.

Highly Cited

2020·

76citations

·R. Vieth

Try another search

identify two things that differentiate depression from sadness site 1

vegan protein powders

what is nortriptyline

nutritional deficiency

pneumococcal pneumonia symptoms

patient teaching for depression